AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $247,200 | -37.5% | 24,000 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $395,520 | +100.8% | 24,000 | +11.6% | 0.01% | +150.0% |
| Q1 2023 | $196,940 | +120.0% | 21,500 | +72.0% | 0.00% | +100.0% |
| Q4 2022 | $89,500 | +31.6% | 12,500 | -7.4% | 0.00% | 0.0% |
| Q3 2022 | $68,000 | +106.1% | 13,500 | 0.0% | 0.00% | – |
| Q2 2022 | $33,000 | -65.6% | 13,500 | -3.6% | 0.00% | -100.0% |
| Q1 2022 | $96,000 | -52.5% | 14,000 | -44.0% | 0.00% | -66.7% |
| Q4 2021 | $202,000 | -18.5% | 25,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $248,000 | +61.0% | 25,000 | +8.7% | 0.00% | +33.3% |
| Q2 2021 | $154,000 | -13.0% | 23,000 | +17.9% | 0.00% | -25.0% |
| Q1 2021 | $177,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |